Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
BlossomHill Therapeutics, Inc. (BLSM) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-60.55M |
|
-- |
|
-- |
|
$64.02M |
|
$-64.02M |
|
$3.47M |
|
$-60.55M |
|
$-60.55M |
|
$-60.55M |
|
$-60.55M |
|
$-60.55M |
|
$-60.55M |
|
$-64.02M |
|
$-63.58M |
|
2.44M |
|
2.44M |
|
$-24.83 |
|
$-24.83 |
|
| Balance Sheet Financials | |
$138.83M |
|
$1.73M |
|
$24.14M |
|
$162.97M |
|
$15.48M |
|
-- |
|
$22.39M |
|
$37.87M |
|
$-131.73M |
|
$125.09M |
|
$125.09M |
|
2.55M |
|
| Cash Flow Statement Financials | |
$-46.92M |
|
$-1.07M |
|
$84.53M |
|
$100.15M |
|
$136.68M |
|
$36.53M |
|
$1.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.97 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-47.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
45.97% |
|
-48.41% |
|
-37.16% |
|
-48.41% |
|
$49.08 |
|
$-19.68 |
|
$-19.25 |
|